Xvivo Perfusion AB Stock price
Equities
XVIVO
SE0004840718
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
275 SEK | 0.00% | -2.65% | -16.54% |
Mar. 16 | Certain Shares of Xvivo Perfusion AB are subject to a Lock-Up Agreement Ending on 16-MAR-2024. | CI |
Jan. 25 | Nordic Shares Moved Upward Thursday; Nokia Topped Leaders | DJ |
Sales 2023 | 598M 56.12M | Sales 2024 * | 804M 75.56M | Capitalization | 8.66B 814M |
---|---|---|---|---|---|
Net income 2023 | 91M 8.55M | Net income 2024 * | 77M 7.23M | EV / Sales 2023 | 16.5 x |
Net cash position 2023 | 515M 48.34M | Net cash position 2024 * | 454M 42.66M | EV / Sales 2024 * | 10.2 x |
P/E ratio 2023 |
107
x | P/E ratio 2024 * |
120
x | Employees | 150 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 75.13% |
Latest transcript on Xvivo Perfusion AB
1 day | +0.36% | ||
1 week | -2.65% | ||
Current month | +1.85% | ||
1 month | +7.21% | ||
3 months | -16.29% | ||
6 months | -0.90% | ||
Current year | -16.54% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 12-08-31 | |
Director of Finance/CFO | 39 | - | |
Chief Tech/Sci/R&D Officer | 57 | 20-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Camilla Öberg
BRD | Director/Board Member | 60 | 16-04-30 |
Chairman | 65 | - | |
Lars Henrikson
BRD | Director/Board Member | 69 | 19-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 275 | 0.00% | 8 886 |
24-03-27 | 275 | +0.73% | 14,401 |
24-03-26 | 273 | -0.55% | 22,965 |
24-03-25 | 274.5 | -1.44% | 19,647 |
24-03-22 | 278.5 | -1.42% | 18,482 |
Delayed Quote Nasdaq Stockholm, March 28, 2024 at 07:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.54% | 816M | |
+3.13% | 197B | |
+5.78% | 115B | |
+0.88% | 71.22B | |
+13.00% | 53.77B | |
+18.30% | 48.75B | |
+6.87% | 44.22B | |
+12.53% | 28.85B | |
+10.49% | 28.57B | |
+10.02% | 27.62B |